GlassScriptPhysician profile
William J Lichtenfeld
NPI 1164422572
$5,959.66
in general payments reported to CMS, 2019-2025
36 companies · $733 in 2025
The $733 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,179 · 2020: $372 · 2021: $723 · 2022: $628 · 2023: $711 · 2024: $1,614 · 2025: $733.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,057.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,057.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $988.99 | 2021-2025 | Intellis Adaptivestim |
| Nevro Corp. | $720.96 | 2019-2024 | Senza |
| Forte Bio-Pharma LLC | $564.73 | 2019-2025 | Prolate, Nalocet, Tanlor |
| Virtus Pharmaceuticals LLC | $357.14 | 2021-2025 | Levorphanol Tartrate |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $320.45 | 2019-2024 | Relistor |
| Grt US Holding, INC. | $297.73 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $241.14 | 2019-2025 | Belbuca |
| Medacta USA, INC. | $208.85 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $202.28 | 2022-2023 | Seglentis |
| Biodelivery Sciences International, INC. | $170.87 | 2019-2021 | |
| Biotronik Nro, INC. | $156.12 | 2024 | Prospera |
| Depuy Synthes Sales INC. | $143.52 | 2019-2025 | Orthovisc |
| Abbott Laboratories | $139.52 | 2023 | Proclaim |
| Globus Medical, INC. | $138.08 | 2025 | Senza |
| Abbvie INC. | $135.66 | 2022-2024 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $126.25 | 2020-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Sentynl Therapeutics, INC. | $113.33 | 2019 | |
| Lilly USA, LLC | $111.75 | 2019-2021 | |
| Amgen INC. | $101.85 | 2019 | |
| Ferring Pharmaceuticals INC. | $89.17 | 2023-2024 | Euflexxa |
| Horizon Therapeutics Plc | $81.73 | 2019-2022 | |
| Averitas Pharma INC. | $73.63 | 2023-2025 | Qutenza |
| Pfizer INC. | $72.91 | 2019-2021 | |
| Merz Pharmaceuticals, LLC | $64.98 | 2022-2023 | Xeomin |
| Novartis Pharmaceuticals Corporation | $63.77 | 2019-2021 | |
| Mdd US Operations, LLC | $51.81 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $51.23 | 2021-2022 | |
| Redhill Biopharma INC. | $34.47 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $23.69 | 2019 | |
| Avanos Medical | $21.33 | 2024 | Trivisc Sodium Hyaluronate |
| Zyla Life Sciences, INC. | $17.36 | 2020 | |
| Vericel Corporation | $17.09 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $16.86 | 2023 | Iovera, Zilretta |
| Assertio Therapeutics, INC. | $14.79 | 2020 | |
| Allergan, INC. | $12.88 | 2019 | |
| Currax Pharmaceuticals LLC | $12.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Lichtenfeld listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.